United Therapeutics is a public benefit corporation that develops and markets therapies for serious diseases with unmet medical needs, primarily pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Its commercial portfolio includes Tyvaso DPI, Nebulized Tyvaso, Remodulin, Remunity infusion pumps, Orenitram, Adcirca, and the oncology product Unituxin for high-risk neuroblastoma. The company also has products in development for PAH, idiopathic pulmonary fibrosis, and progressive pulmonary fibrosis. Its mission extends to expanding the availability of transplantable organs through innovative organ manufacturing technologies.
expected 2027-01-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001082554-26-000006 | EDGAR | 82K words |
| 2025-02-26 | 2024-12-31 | 0001082554-25-000005 | EDGAR | 85K words |
| 2024-02-21 | 2023-12-31 | 0001082554-24-000005 | EDGAR | 85K words |
| 2023-02-22 | 2022-12-31 | 0001082554-23-000005 | EDGAR | 82K words |
| 2022-02-24 | 2021-12-31 | 0001082554-22-000004 | EDGAR | 85K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-04 | 2026-09-30 | 0001082554-26-000035 | EDGAR | 45K words |
| 2026-08-05 | 2026-06-30 | 0001082554-26-000027 | EDGAR | 44K words |
| 2025-10-29 | 2025-09-30 | 0001082554-25-000034 | EDGAR | 42K words |
| 2025-07-30 | 2025-06-30 | 0001628280-25-036541 | EDGAR | 41K words |
| 2025-04-30 | 2025-03-31 | 0001082554-25-000023 | EDGAR | 38K words |
| 2024-10-30 | 2024-09-30 | 0001082554-24-000047 | EDGAR | 42K words |
| 2024-07-31 | 2024-06-30 | 0001082554-24-000035 | EDGAR | 43K words |
| 2024-05-01 | 2024-03-31 | 0001082554-24-000025 | EDGAR | 40K words |
| 2023-11-01 | 2023-09-30 | 0001082554-23-000031 | EDGAR | 42K words |
| 2023-08-02 | 2023-06-30 | 0001082554-23-000022 | EDGAR | 41K words |
| 2023-05-03 | 2023-03-31 | 0001082554-23-000012 | EDGAR | 38K words |
| 2022-11-02 | 2022-09-30 | 0001082554-22-000026 | EDGAR | 42K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-04 | 0001082554-26-000036 | EDGAR | 4K words |
| 2026-10-22 | 0001104659-26-117964 | EDGAR | 1K words |
| 2026-10-14 | 0001104659-26-115723 | EDGAR | 11K words |
| 2026-09-08 | 0001104659-26-105953 | EDGAR | 1K words |
| 2026-08-05 | 0001082554-26-000028 | EDGAR | 4K words |
| 2026-07-23 | 0001104659-26-086068 | EDGAR | 1K words |
| 2026-03-30 | 0001104659-26-036445 | EDGAR | 2K words |
| 2026-03-09 | 0001104659-26-025331 | EDGAR | 1K words |
| 2026-03-02 | 0001104659-26-021869 | EDGAR | 2K words |
| 2026-02-25 | 0001082554-26-000007 | EDGAR | 5K words |
80 total filings indexed. 53 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001082554 |
| Ticker | UTHR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Silver Spring, Maryland and Durham |
| Website | https://www.unither.com |
| Listed | 1999-06-17 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/UTHR (~200 tokens, structured JSON with cryptographic provenance)